Top-News

Codiak Biosciencedl-,0001 News

Aktie
WKN:  A2PJN7 ISIN:  US1920101060 US-Symbol:  CDAKQ
Keine aktuellen Kursdaten verfügbar
Handeln Depot/Watchlist
Dieses Wertpapier ist nicht mehr handelbar.
Aktienanzahl *
22,49 Mio.
Marktkapitalisierung *
-
Streubesitz
-
Index-Zugehörigkeit
-
*Stand: 06.07.2022

Codiak Biosciencedl-,0001 News

18.08.22 - PR Newswire
Thinking about buying stock in Endo International, FuelCell Energy, Cassava Sciences, Codiak BioSciences, or Teva Pharmaceutical?
Thinking about buying stock in Endo International, FuelCell Energy, Cassava Sciences, Codiak BioSciences, or Teva Pharmaceutical? PR Newswire
28.02.22 - PR Newswire
Alltrna Appoints Rare Disease Clinical Research Expert, Dr. Anne Pariser, as Vice President, Medical and Regulatory Affairs
Alltrna Appoints Rare Disease Clinical Research Expert, Dr. Anne Pariser, as Vice President, Medical and Regulatory Affairs PR Newswire
15.02.22 - PR Newswire
INVAIO SCIENCES STRENGTHENS ITS BOARD OF DIRECTORS WITH THE APPOINTMENT OF HUGH GRANT
INVAIO SCIENCES STRENGTHENS ITS BOARD OF DIRECTORS WITH THE APPOINTMENT OF HUGH GRANT PR Newswire
25.05.21 - PR Newswire
Invaio Sciences Raises $88.9 Million to Accelerate the Transition to Biological Agriculture
Invaio Sciences Raises $88.9 Million to Accelerate the Transition to Biological Agriculture PR Newswire
19.05.21 - PR Newswire
Invaio Sciences Announces Key Agreement with Fundecitrus in Brazil to Combat Against Citrus Greening
Invaio Sciences Announces Key Agreement with Fundecitrus in Brazil to Combat Against Citrus Greening PR Newswire
30.03.21 - PR Newswire
Invaio Sciences Strengthens Leadership Team with Appointment of Peleg Chevion as President and Chief Commercial Officer
Invaio Sciences Strengthens Leadership Team with Appointment of Peleg Chevion as President and Chief Commercial Officer PR Newswire
25.02.21 - PR Newswire
Cellarity Raises $123 Million in Series B Funding to Pioneer a New Approach to Drug Discovery, Treating Disease at the Level of the Cell as Opposed to a Single Molecular Target
Cellarity Raises $123 Million in Series B Funding to Pioneer a New Approach to Drug Discovery, Treating Disease at the Level of the Cell as Opposed to a Single Molecular Target ...

Newssuche

Videos

newspaper
17.05.24 +14,15%
Technical Trading: Gold Long-​Chance
Gold Long Typ: Turbo Open End WKN: VD1G7Y Hebel: 10 Laufzeit: OpenEnd Einstieg: Market ... Mehr »